Revision history of "Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines" (Q2105797)

From MaRDI portal

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

17 December 2024

31 July 2024

20 March 2024

5 March 2024

29 February 2024

15 February 2024

1 February 2024

31 July 2023